Back

Mismatch between pre-clinical cardio-oncology and clinical oncology research

20 June 2025 (10:42 - 10:51)
Organised by: Logo
Congress Presentation Part of: Mechanisms of cancer treatment-related cardiovascular toxicity Research and New Technology CCO Premium Access ESC Cardio-Oncology 2025 Council of Cardio-Oncology

About the speaker

Photo
Doctor Mario Stabile

0012o00002IMl8MAA, Genoa (Italy)

4 More presentations in this session

Presentation thumbnail
CDK4/6 inhibitor ribociclib induces cardiotoxicity through impaired E2F1-regulated spliceosome assembly
Ms E. Pet (Groningen, NL)
Abstract Slides Video
Presentation thumbnail
Targeted cardiac inactivation of Guanylate binding protein 5 (GBP5) protects from cardiotoxicity after radiation
Doctor M. Heckmann (Heidelberg, DE)
Abstract Slides Video
Presentation thumbnail
Cell painting based high-content phenotypic screening to elucidate kinase signaling pathways in ibrutinib-mediated atrial fibrillation
Doctor M. Fleming (Jacksonville, US)
Abstract Slides Video
Presentation thumbnail
Early myocardial metabolic signatures of anthracycline-induced cardiotoxicity
Mr C. Galan (Madrid, ES)
Abstract Slides Video

Access the full session

Session thumbnail
Mechanisms of cancer treatment-related cardiovascular toxicity

The Event

Event poster

ESC Cardio-Oncology 2025

20 June 2025 10:42 CET
You may be interested in
thumbnail
Congress Presentation
How to advance translational research to inform cardio-oncology practice
thumbnail
Congress Presentation
Future directions
thumbnail
Congress Presentation
Quality standards

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources